There were 1,827 press releases posted in the last 24 hours and 359,048 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AveXis and REGENXBIO Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image